Skip to main content
Clinical Trials/NCT06086717
NCT06086717
Completed
Not Applicable

Comparison of Kinesio Taping and Dry Needling in the Management of Grade 1, 2 Knee Osteoarthritis

Riphah International University1 site in 1 country30 target enrollmentJanuary 12, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis, Knee
Sponsor
Riphah International University
Enrollment
30
Locations
1
Primary Endpoint
Pain Score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study's aim was:

  • To determine the effects of kinesio taping and dry needling on pain, ROMs, functional mobility, and quality of life in knee OA patients.

Detailed Description

This was a randomized clinical trial in which Grade 1, 2 Knee Osteoarthritis patients were randomized into two groups: Group-A and Group-B. Group-A participants received Kinesio taping while Group-B participants received dry needling as an adjunct to the conventional physical therapy treatment. The intervention was carried out for four weeks with frequency of two sessions per week. Outcome measures were assessed at baseline, after two weeks, and after 4 weeks, using Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee Range of Motion (ROM), and SF-12 Quality of Life Questionnaire.

Registry
clinicaltrials.gov
Start Date
January 12, 2022
End Date
January 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed patients of grade 1, 2 knee OA (Kallgren and Lawrence).
  • Pain and/or tenderness around knee joint
  • Knee OA patients with tightness in Quadriceps, Hamstrings, and Iliotibial band.
  • Patients with pain of \>4 on VAS.

Exclusion Criteria

  • Patients who had received Intra-articular Steroid injections in knee joints.
  • Patients who had suffered a traumatic injury to knee joint within past 6 months prior to this study.
  • Patients with any surgical intervention to the knee joints.
  • Patients with peripheral vascular disease.
  • Patients with diagnosed tumors, malignancies, infection associated with knee joint.
  • Patients with lower limb metallic implants.

Outcomes

Primary Outcomes

Pain Score

Time Frame: Baseline, after 2 weeks, and after 4 weeks.

Pain was measured using Visual Analog Scale on a score from zero (0=no pain) to ten (10=worst pain possible).

Knee ROM

Time Frame: Baseline, after 2 weeks, and after 4 weeks.

Knee ROM (flexion and extension) was assessed using universal goniometer.

Secondary Outcomes

  • Quality of Life Score(Baseline, after 2 weeks, and after 4 weeks.)
  • WOMAC Score(Baseline, after 2 weeks, and after 4 weeks.)

Study Sites (1)

Loading locations...

Similar Trials